A Single Dose of ChAdOx1 nCoV-19 Vaccine Elicits High Antibody Responses in Individuals with Prior SARS-CoV-2 Infection Comparable to That of Two-Dose-Vaccinated, SARS-CoV-2-Infection-Naïve Individuals: A Longitudinal Study in Ethiopian Health Workers

Single-dose COVID-19 vaccines, mostly mRNA-based vaccines, are shown to induce robust antibody responses in individuals who were previously infected with SARS-CoV-2, suggesting the sufficiency of a single dose for those individuals in countries with limited vaccine supply. However, these important d...

Descripción completa

Detalles Bibliográficos
Autores principales: Gelanew, Tesfaye, Mulu, Andargachew, Abebe, Markos, Bates, Timothy A., Wassie, Liya, Teferi, Mekonnen, Fentahun, Dessalegn, Alemu, Aynalem, Tamiru, Frehiwot, Assefa, Gebeyehu, Bayih, Abebe Genetu, Tafesse, Fikadu G., Mihret, Adane, Abdissa, Alemseged
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9229151/
https://www.ncbi.nlm.nih.gov/pubmed/35746467
http://dx.doi.org/10.3390/vaccines10060859

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9229151/
https://www.ncbi.nlm.nih.gov/pubmed/35746467
http://dx.doi.org/10.3390/vaccines10060859

Ejemplares similares